                         SEQUENCE LISTING

<110>  Technische Universitt Mnchen
 
<120>  COMBINATION OF REVERSIBLE AND IRREVERSIBLE CELL LABELING FOR 
       ANALIZING RECEPTOR-LIGAND KOFF RATE

<130>  TUM15690PCT

<150>  EP 16176537.5
<151>  2016-06-28

<160>  16    

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  streptavidin-binding peptide

<400>  1

Trp Ser His Pro Gln Phe Glu Lys 
1               5               


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  streptaviding analog (aa44-47)

<400>  2

Val Thr Ala Arg 
1               


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  streptaviding analog (aa44-47)

<400>  3

Ile Gly Ala Arg 
1               


<210>  4
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  FLAG-tag

<400>  4

Asp Tyr Lys Asp Asp Asp Asp Lys 
1               5               


<210>  5
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Myc-tag

<400>  5

Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu 
1               5                   10  


<210>  6
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HA-tag

<400>  6

Tyr Pro Tyr Asp Val Pro Asp Tyr Ala 
1               5                   


<210>  7
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VSV-G-tag

<400>  7

Tyr Thr Asp Ile Glu Met Asn Arg Leu Gly Lys 
1               5                   10      


<210>  8
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HSV-tag

<400>  8

Gln Pro Glu Leu Ala Pro Glu Asp Pro Glu Asp 
1               5                   10      


<210>  9
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  V5-tag

<400>  9

Gly Lys Pro Ile Pro Asn Pro Leu Leu Gly Leu Asp Ser Thr 
1               5                   10                  


<210>  10
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide in complex with H2Kb

<400>  10

Ser Ile Tyr Arg Tyr Tyr Gly Leu 
1               5               


<210>  11
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  di-tag3

<400>  11

Trp Ser His Pro Gln Phe Glu Lys Gly Gly Gly Ser Gly Gly Gly Ser 
1               5                   10                  15      


Gly Gly Gly Ser Trp Ser His Pro Gln Phe Glu Lys 
            20                  25              


<210>  12
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  di-tag2

<400>  12

Trp Ser His Pro Gln Phe Glu Lys Gly Gly Gly Ser Gly Gly Gly Ser 
1               5                   10                  15      


Trp Ser His Pro Gln Phe Glu Lys 
            20                  


<210>  13
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Twin-Strep-tag

<400>  13

Trp Ser His Pro Gln Phe Glu Lys Gly Gly Gly Ser Gly Gly Gly Ser 
1               5                   10                  15      


Gly Gly Ser Ala Trp Ser His Pro Gln Phe Glu Lys 
            20                  25              


<210>  14
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide in complex with H2kb

<400>  14

Ser Ile Ile Gln Phe Glu Lys Leu 
1               5               


<210>  15
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide in complex with H2kb

<400>  15

Ser Ile Tyr Asn Phe Glu Lys Leu 
1               5               


<210>  16
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide in complex with H2kb

<400>  16

Ser Ile Ile Asn Phe Glu Lys Leu 
1               5               


